3-20040542-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003884.5(KAT2B):c.65C>T(p.Pro22Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000515 in 1,009,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003884.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KAT2B | NM_003884.5 | c.65C>T | p.Pro22Leu | missense_variant | 1/18 | ENST00000263754.5 | NP_003875.3 | |
KAT2B | XM_005265528.5 | c.65C>T | p.Pro22Leu | missense_variant | 1/17 | XP_005265585.1 | ||
KAT2B | XM_047449147.1 | c.-431C>T | 5_prime_UTR_variant | 1/20 | XP_047305103.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KAT2B | ENST00000263754.5 | c.65C>T | p.Pro22Leu | missense_variant | 1/18 | 1 | NM_003884.5 | ENSP00000263754.4 |
Frequencies
GnomAD3 genomes AF: 0.0000889 AC: 13AN: 146158Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000452 AC: 39AN: 863120Hom.: 0 Cov.: 25 AF XY: 0.0000372 AC XY: 15AN XY: 402820
GnomAD4 genome AF: 0.0000889 AC: 13AN: 146266Hom.: 0 Cov.: 31 AF XY: 0.0000702 AC XY: 5AN XY: 71186
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.65C>T (p.P22L) alteration is located in exon 1 (coding exon 1) of the KAT2B gene. This alteration results from a C to T substitution at nucleotide position 65, causing the proline (P) at amino acid position 22 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at